Skip to content

    Recently Viewed

      Listening...

      Johnson & Johnson to Participate in Citi’s 2022 Virtual Healthcare Conference

      Share Article
      share to

      New Brunswick, NJ (January 27th, 2022) - Johnson & Johnson (NYSE: JNJ) will participate in Citi’s 2022 Virtual Healthcare Conference on Wednesday, February 23rd, Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices will represent the Company in a session scheduled at 11:00 a.m. (Eastern Time).

      This conference call will be available to investors and other interested parties by visit the Johnson & Johnson website at www.investor.jnj.com.

      A webcast and podcast replay will be available approximately 48 hours after the live webcast.

      Media Contacts
      Stephanie Hartgrove
      (732) 524-1941

      Investor Contacts
      Sarah Wood
      (732) 524-2617

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.